Global Electrophysiology Devices Market Size, Share, Growth, And Forecast 2026-2035 Pulsed Field Ablation And 3D Mapping Fuel 12.40% CAGR To USD 30.16 Billion By 2035
Dublin, Oct. 15, 2026 (GLOBE NEWSWIRE) -- "Electrophysiology Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)" has been added to ResearchAndMarkets.com's offering.
The global electrophysiology devices market was valued at USD 9.37 Billion in 2025 and is projected to reach USD 30.16 Billion by 2035, expanding at a CAGR of 12.40% during 2026-2035. Market growth is supported by the rising prevalence of atrial fibrillation and other cardiac arrhythmias, increasing use of minimally invasive procedures, rapid adoption of pulsed field ablation systems, and wider deployment of advanced 3D mapping platforms in hospitals and ambulatory surgical centres.
Recent Electrophysiology Devices Market Developments
April 2026: Stereotaxis Receives FDA 510(k) Clearance
On April 6, 2026, Stereotaxis announced FDA 510(k) clearance for the Synchrony System, a digital cockpit developed for robotic electrophysiology laboratories. The system combines 4K visualisation, multi-system control, and SynX cloud connectivity. According to DAIC, the platform is designed to streamline complex ablation procedures and support the transition toward digital, robotically navigated cardiac care.
March 2026: Boston Scientific Secures Expanded CE Mark
Boston Scientific received expanded CE mark approval on March 3, 2026 for its Farapulse Pulsed Field Ablation System to treat persistent atrial fibrillation. The approval was supported by positive ADVANTAGE AF clinical trial data. As reported by Cardiovascular Business, the expanded European indication reinforces the company's position in pulsed field ablation and intensifies competition within the global electrophysiology devices market.
Market Size and Key Insights
- Market size in 2025: USD 9.37 Billion Projected market size in 2035: USD 30.16 Billion Forecast CAGR for 2026-2035: 12.40% Largest regional market in 2025: North America Atrial fibrillation share in the historical period: Approximately 73% Leading end user during the forecast period: Hospitals North America's historical market share: Approximately 49%
Rising Atrial Fibrillation Burden Drives Market Growth
The increasing global incidence of cardiac arrhythmias remains a major driver of demand for electrophysiology devices. According to Siyuan Cheng et al., 2024, atrial fibrillation and flutter affected approximately 52.55 million people worldwide in 2021, with 4.48 million new cases recorded during the year. This expanding patient population is increasing demand for catheter ablation, diagnostic mapping, continuous monitoring, and advanced cardiac rhythm management.
Market expansion is also being supported by technological advances in AI diagnostics, clinical decision support, remote patient monitoring, and biomarker-based treatment selection. These capabilities can improve patient stratification, procedural planning, and clinical efficiency across electrophysiology laboratories.
Pulsed Field Ablation Emerges as a Major Market Trend
Pulsed field ablation is gaining clinical acceptance as an important alternative to conventional thermal ablation for atrial fibrillation. Its growing adoption is being driven by improvements in procedural efficiency, safety, and treatment precision. In January 2024, Boston Scientific received U.S. FDA approval for its FARAPULSET pulsed field ablation system for atrial fibrillation following positive clinical outcomes and real-world safety findings.
Continued investment in next-generation ablation platforms is expected to strengthen competition among medical device manufacturers. Integration with advanced mapping, navigation, and recording systems will further support adoption in complex electrophysiology procedures.
Electrophysiology Devices Market Segmentation
By Product
- Equipment EP Laboratory Capital Equipment 3-D Mapping Systems Recording Systems RF Generators and Cryo Consoles Implantable Electrophysiology Devices Cardiac Pacemakers Implantable Cardioverter-Defibrillators (ICDs) Diagnostic EP Catheters Ablation Catheters Others
By Application
- Atrial Fibrillation Atrial Flutter Atrioventricular Nodal Re-entrant Tachycardia (AVNRT) Wolff-Parkinson-White (WPW) Syndrome Ventricular Tachycardia Other Arrhythmias
By End User
- Hospitals Ambulatory Surgical Centers Cardiac Electrophysiology Laboratories Academic and Research Institute
By Region
- North America Europe Asia Pacific Latin America Middle East and Africa
Catheters Positioned for Significant Growth
The catheter segment is expected to record substantial growth due to its essential role in diagnostic mapping and minimally invasive ablation procedures. Rising procedure volumes, increasing treatment of complex arrhythmias, and continued innovation in catheter design are strengthening demand. Product launches and regulatory approvals recorded during 2024 and 2025 are also supporting the segment's long-term outlook.
North America Maintains Market Leadership
North America is expected to lead the electrophysiology devices market due to its advanced healthcare infrastructure, high prevalence of atrial fibrillation, established reimbursement environment, and extensive network of specialised electrophysiology laboratories. In April 2025, Merit Medical Systems, Inc. announced the United States commercial launch of its Ventrax delivery system, developed to improve catheter access during ventricular tachycardia ablation procedures. The launch reflects continued regional investment in technologies that enhance procedural efficiency and clinical outcomes.
Leading Electrophysiology Device Companies
Major market participants are advancing their positions through product approvals, clinical research, patent activity, funding, partnerships, and portfolio expansion.
- Medtronic plc: Medtronic supplies the PulseSelect and Affera Pulsed Field Ablation systems. In October 2024, the company received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, giving it two FDA-approved PFA platforms for atrial fibrillation. Boston Scientific Corporation: Boston Scientific offers cardiac mapping, radiofrequency ablation, and rhythm management technologies. Its portfolio includes the S-ICDT System and the Farapulse Pulsed Field Ablation System. Abbott Laboratories: Abbott provides cardiac mapping, ablation, and rhythm management products, including the EnSite X EP system. In March 2025, it received CE mark approval for the Volt Pulsed Field Ablation System for atrial fibrillation. Biotronik SE & Co KG: Biotronik develops pacemakers, implantable cardioverter defibrillators, CRT-D systems, and remote patient monitoring solutions across more than 100 countries.
Other prominent companies include Biosense Webster, Inc., GE HealthCare Technologies Inc., MicroPort Scientific Corporation, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., and CathVision ApS.
The report assesses market size, growth drivers, restraints, opportunities, product and application segments, regional performance, competitive strategies, patent activity, grants, funding, investment, partnerships, mergers, and acquisitions shaping the electrophysiology devices market through 2035.
Key Topics Covered:
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Electrophysiology Devices Market Overview
3.1 Global Electrophysiology Devices Market Historical Value (2019-2025)
3.2 Global Electrophysiology Devices Market Forecast Value (2026-2035)
4 Global Electrophysiology Devices Market Landscape
4.1 Global Electrophysiology Devices Market: Developer Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Electrophysiology Devices Market: Product Landscape
4.2.1 Analysis by Product
5 Global Electrophysiology Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environmental
5.4 Porter's Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Global Electrophysiology Devices Market Segmentation (2019-2035)
6.1 Global Electrophysiology Devices Market (2019-2035) by Product
6.1.1 Equipment
6.1.1.1 EP Laboratory Capital Equipment
6.1.1.1.1 3-D Mapping Systems
6.1.1.1.2 Recording Systems
6.1.1.1.3 RF Generators and Cryo Consoles
6.1.1.1.4 Others
6.1.1.2 Implantable Electrophysiology Devices
6.1.1.2.1 Cardiac Pacemakers
6.1.1.2.2 Implantable Cardioverter-Defibrillators (ICDs)
6.1.2 Catheters
6.1.2.1 Diagnostic EP Catheters
6.1.2.2 Ablation Catheters
6.1.3 Others
6.2 Global Electrophysiology Devices Market (2019-2035) by Application
6.2.1 Atrial Fibrillation
6.2.2 Atrial Flutter
6.2.3 Atrioventricular Nodal Re-entrant Tachycardia (AVNRT)
6.2.4 Wolff-Parkinson-White (WPW) Syndrome
6.2.5 Ventricular Tachycardia
6.2.6 Other Arrhythmias
6.3 Global Electrophysiology Devices Market (2019-2035) by End User
6.3.1 Hospitals
6.3.2 Ambulatory Surgical Centers
6.3.3 Cardiac Electrophysiology Laboratories
6.3.4 Academic and Research Institutes
6.4 Global Electrophysiology Devices Market (2019-2035) by Region
6.4.1 North America
6.4.2 Europe
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 Middle East and Africa
7 North America Electrophysiology Devices Market (2019-2035)
7.1 North America Electrophysiology Devices Market by Product
7.2 North America Electrophysiology Devices Market by Application
7.3 North America Electrophysiology Devices Market by End User
7.4 North America Electrophysiology Devices Market by Country
7.4.1 United States
7.4.2 Canada
8 Europe Electrophysiology Devices Market (2019-2035)
8.1 Europe Electrophysiology Devices Market by Product
8.2 Europe Electrophysiology Devices Market by Application
8.3 Europe Electrophysiology Devices Market by End User
8.4 Europe Electrophysiology Devices Market by Country
8.4.1 United Kingdom
8.4.2 Germany
8.4.3 France
8.4.4 Italy
8.4.5 Spain
8.4.6 Others
9 Asia Pacific Electrophysiology Devices Market (2019-2035)
9.1 Asia Pacific Electrophysiology Devices Market by Product
9.2 Asia Pacific Electrophysiology Devices Market by Application
9.3 Asia Pacific Electrophysiology Devices Market by End User
9.4 Asia Pacific Electrophysiology Devices Market by Country
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 ASEAN
9.4.5 Australia
9.4.6 Others
10 Latin America Electrophysiology Devices Market (2019-2035)
10.1 Latin America Electrophysiology Devices Market by Product
10.2 Latin America Electrophysiology Devices Market by Application
10.3 Latin America Electrophysiology Devices Market by End User
10.4 Latin America Electrophysiology Devices Market by Country
10.4.1 Brazil
10.4.2 Argentina
10.4.3 Mexico
10.4.4 Others
11 Middle East and Africa Electrophysiology Devices Market (2019-2035)
11.1 Middle East and Africa Electrophysiology Devices Market by Product
11.2 Middle East and Africa Electrophysiology Devices Market by Application
11.3 Middle East and Africa Electrophysiology Devices Market by End User
11.4 Middle East and Africa Electrophysiology Devices Market by Country
11.4.1 Saudi Arabia
11.4.2 United Arab Emirates
11.4.3 Nigeria
11.4.4 South Africa
11.4.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.2 US FDA
12.3 EU EMA
12.4 India CDSCO
12.5 Japan PMDA
12.6 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Codes
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Initiatives
15.3 Analysis by Joint Ventures
15.4 Analysis by Leading Players
15.5 Analysis by Geography
16 Supplier Landscape
16.1 Vendor Positioning Analysis
16.1.1 Key Vendors
16.1.2 Prospective Leaders
16.1.3 Niche Leaders
16.1.4 Disruptors
16.2 Market Share Analysis by Region (Top 5 Companies)
16.3 Company Assessment Framework
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Geographic Reach and Achievements
16.3.4 Company News and Developments
16.3.5 Certifications
16.4 Company Profiles
16.4.1 Medtronic plc.
16.4.2 Boston Scientific Corporation
16.4.3 Abbott Laboratories
16.4.4 Biosense Webster, Inc. (part of Johnson & Johnson MedTech)
16.4.5 GE HealthCare Technologies Inc.
16.4.6 Biotronik SE & Co. KG
16.4.7 MicroPort Scientific Corporation
16.4.8 Koninklijke Philips N.V.
16.4.9 Lepu Medical Technology (Beijing) Co., Ltd.
16.4.10 CathVision ApS
17 Global Electrophysiology Devices Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
Companies Featured
- Medtronic plc Boston Scientific Corporation Abbott Laboratories Biotronik SE & Co KG
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment